Related Experiment Videos
Structure and function of collagen-derived endostatin inhibitors of angiogenesis
Takako Sasaki1, Erhard Hohenester, Rupert Timpl
1Max-Planck-Institut für Biochemie, Martinsried, Germany.
Abstract:
Endostatins are inhibitors of endothelial cell migration and angiogenesis and have been shown to reduce tumor growth in animal models. They are derived from the nontriplehelical C-terminal NC1 domains of collagens XV and XVIII, which are released proteolytically in trimeric form and further converted to monomeric endostatins of about 20 kDa. Both endostatin isoforms share a compact globular fold, but differ in certain binding properties for proteins and cells, as well as in tissue distribution. Differences in activity were found between NC1 domains and endostatins and are related to the oligomerization state. Endostatin effects are not restricted to endothelial cells, but also control renal epithelial cells and neuronal guidance in C. elegans. Cellular receptors are still insufficiently characterized and include for endostatin-XVIII heparan sulfate proteoglycans. Receptor engagement elicits various downstream effects including tyrosine kinase and gene activation. Much remains to be learned, however, about details of the signal transduction cascades and how they interfere with pro-angiogenic factors under physiological conditions and during therapeutic treatment.
Insights
Endostatins, derived from collagen, inhibit blood vessel growth and tumor expansion. These molecules impact various cells beyond endothelial cells, with ongoing research into their precise mechanisms and therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Endostatins are collagen-derived peptides inhibiting angiogenesis and tumor growth.
- They originate from collagen XV and XVIII NC1 domains, existing as trimers and monomers.
- Endostatin isoforms exhibit distinct binding and tissue distribution profiles.
Purpose of the Study:
- To summarize the properties and functions of endostatins.
- To highlight their broader cellular effects beyond endothelial cells.
- To identify current knowledge gaps in endostatin signaling and receptor interactions.
Main Methods:
- Literature review and synthesis of existing research on endostatins.
- Analysis of structural and functional differences between endostatin isoforms.
- Review of studies on endostatin's cellular targets and signaling pathways.
Main Results:
- Endostatins effectively inhibit endothelial cell migration and angiogenesis, reducing tumor growth in models.
- Both endostatin isoforms share a globular structure but differ in binding and distribution.
- Endostatin's effects extend to renal epithelial cells and neuronal guidance, with heparan sulfate proteoglycans as a known receptor for endostatin-XVIII.
Conclusions:
- Endostatins are potent anti-angiogenic agents with therapeutic potential.
- Their mechanisms involve complex downstream signaling, including tyrosine kinase and gene activation.
- Further research is needed to fully elucidate endostatin signal transduction and its interaction with pro-angiogenic factors.